Know Labs’ first study including participants with diabetes and venous blood as a comparative reference demonstrates its proprietary sensor’s accuracy and medical application. SEATTLE--(BUSINESS WIRE) ...
The MarketWatch News Department was not involved in the creation of this content. Landmark trials at Mayo Clinic and Cleveland Clinic support market adoptions of breakthrough AI-powered wearable for ...
Afon Technology, aims to transform diabetes management with its non-invasive glucose monitoring device, GlucowearTM ...
Now available for pre-order, RIZZ brings real-time glucose, sleep, and stress tracking to your finger without sensors, pricks, or prescriptions. This is more than a ring. It’s a leap toward accessible ...
No more gruesome needle pricks to monitor blood sugar levels. New research reveals that natural glucose fluctuations, tracked by wearables, may provide doctors with all the information they need to ...
Liom, a pioneer in non-invasive biomarker monitoring and the developer of the world’s first non-invasive glucose-monitoring wearable, today announced a CHF 13 million extension of its Series A ...
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced the KnowU™, its wearable non-invasive continuous ...
Scientific American recently published a feature on wireless enabled and needle-free, continuous blood glucose monitoring company Echo Therapeutics, which was one of the few startups in wireless ...
Nemaura Medical, Inc. is a medical technology company developing and commercializing non-invasive wearable diagnostic devices. The company is currently commercializing sugarBEAT ® and proBEAT ™.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback